157 related articles for article (PubMed ID: 21885139)
1. External beam radiotherapy combined with intraluminal brachytherapy in esophageal carcinoma.
Muijs CT; Beukema JC; Mul VE; Plukker JT; Sijtsema NM; Langendijk JA
Radiother Oncol; 2012 Feb; 102(2):303-8. PubMed ID: 21885139
[TBL] [Abstract][Full Text] [Related]
2. Comparison of efficacy and safety of low-dose-rate vs. high-dose-rate intraluminal brachytherapy boost in patients with superficial esophageal cancer.
Tamaki T; Ishikawa H; Takahashi T; Tamaki Y; Kitamoto Y; Okamoto M; Noda SE; Katoh H; Shirai K; Sakurai H; Nakano T
Brachytherapy; 2012; 11(2):130-6. PubMed ID: 21700506
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant interstitial high-dose-rate (HDR) brachytherapy combined with systemic chemotherapy in patients with breast cancer.
Roddiger SJ; Kolotas C; Filipowicz I; Kurek R; Kuner RP; Martin T; Baltas D; Rogge B; Kontova M; Hoffmann G; Pollow B; Zamboglou N
Strahlenther Onkol; 2006 Jan; 182(1):22-9. PubMed ID: 16404517
[TBL] [Abstract][Full Text] [Related]
4. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
5. Palliation of dysphagia in advanced, metastatic or recurrent carcinoma oesophagus with high dose rate intraluminal brachytherapy--an eastern Indian experience of 35 cases.
Ghosh S; Sau S; Mitra S; Manna A; Ghosh K
J Indian Med Assoc; 2012 Jul; 110(7):449-52. PubMed ID: 23520668
[TBL] [Abstract][Full Text] [Related]
6. Californium-252 neutron brachytherapy combined with external beam radiotherapy for esophageal cancer: long-term treatment results.
Liu H; Wang Q; Wan X; Jia X; Liu B; Wang CK
Brachytherapy; 2014; 13(5):514-21. PubMed ID: 24818780
[TBL] [Abstract][Full Text] [Related]
7. Radical radiotherapy incorporating a brachytherapy boost for the treatment of carcinoma of the thoracic oesophagus: results from a cohort of patients and review of the literature.
Churn M; Jones B; Myint AS
Clin Oncol (R Coll Radiol); 2002 Apr; 14(2):117-22. PubMed ID: 12069118
[TBL] [Abstract][Full Text] [Related]
8. High dose rate brachytherapy for superficial cancer of the esophagus.
Maingon P; d'Hombres A; Truc G; Barillot I; Michiels C; Bedenne L; Horiot JC
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(1):71-6. PubMed ID: 10656375
[TBL] [Abstract][Full Text] [Related]
9. Randomized prospective study comparing high-dose-rate intraluminal brachytherapy (HDRILBT) alone with HDRILBT and external beam radiotherapy in the palliation of advanced esophageal cancer.
Sur R; Donde B; Falkson C; Ahmed SN; Levin V; Nag S; Wong R; Jones G
Brachytherapy; 2004; 3(4):191-5. PubMed ID: 15607150
[TBL] [Abstract][Full Text] [Related]
10. Salvage high-dose-rate brachytherapy for esophageal cancer in previously irradiated patients: A retrospective analysis.
Wong Hee Kam S; Rivera S; Hennequin C; Lourenço N; Chirica M; Munoz-Bongrand N; Gornet JM; Quéro L
Brachytherapy; 2015; 14(4):531-6. PubMed ID: 25906950
[TBL] [Abstract][Full Text] [Related]
11. Combination external beam radiotherapy and intraluminal brachytherapy for non-radical treatment of oesophageal carcinoma in patients not suitable for surgery or chemoradiation.
Aggarwal A; Harrison M; Glynne-Jones R; Sinha-ray R; Cooper D; Hoskin PJ
Clin Oncol (R Coll Radiol); 2015 Jan; 27(1):56-64. PubMed ID: 25306490
[TBL] [Abstract][Full Text] [Related]
12. A phase I/II study of external beam radiation, brachytherapy, and concurrent chemotherapy for patients with localized carcinoma of the esophagus (Radiation Therapy Oncology Group Study 9207): final report.
Gaspar LE; Winter K; Kocha WI; Coia LR; Herskovic A; Graham M
Cancer; 2000 Mar; 88(5):988-95. PubMed ID: 10699886
[TBL] [Abstract][Full Text] [Related]
13. External beam radiation therapy followed by high-dose-rate brachytherapy for inoperable superficial esophageal carcinoma.
Pasquier D; Mirabel X; Adenis A; Rezvoy N; Hecquet G; Fournier C; Coche-Dequeant B; Prevost B; Castelain B; Lartigau E
Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1456-61. PubMed ID: 16863928
[TBL] [Abstract][Full Text] [Related]
14. Intraluminal brachytherapy boost following external beam radiotherapy with concurrent chemotherapy of oesophagus carcinoma: Results of a prospective observational study.
Nag P; Gurjar OP; Bhandari V; Gupta KL; Bagdare P; Goyal H
Cancer Radiother; 2018 Apr; 22(2):163-166. PubMed ID: 29615371
[TBL] [Abstract][Full Text] [Related]
15. Severe complications after hypofractionated high dose rate intracavitary brachytherapy following external beam irradiation for oesophageal carcinoma.
Hama Y; Uematsu M; Shioda A; Suda A; Aida S; Kusano S
Br J Radiol; 2002 Mar; 75(891):238-42. PubMed ID: 11932217
[TBL] [Abstract][Full Text] [Related]
16. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
[TBL] [Abstract][Full Text] [Related]
17. Concomitant chemotherapy and external radiotherapy plus brachytherapy for locally advanced esophageal cancer: results of a retrospective multicenter study.
Tessa M; Rotta P; Ragona R; Sola B; Grassini M; Nassisi D; Sciacero P; Airoldi M; Filippi A; Gianello L; De Angelis C; Ozzello F; Trotti AB; Ricardi U; Sannazzari GL
Tumori; 2005; 91(5):406-14. PubMed ID: 16459637
[TBL] [Abstract][Full Text] [Related]
18. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
[TBL] [Abstract][Full Text] [Related]
19. Primary radiotherapy with or without chemotherapy in non-metastatic esophageal squamous cell carcinoma: a retrospective study.
Fakhrian K; Heilmann J; Schuster T; Thamm R; Reuschel W; Molls M; Geinitz H
Dis Esophagus; 2012 Apr; 25(3):256-62. PubMed ID: 21899651
[TBL] [Abstract][Full Text] [Related]
20. High dose-rate endoluminal brachytherapy for primary and recurrent esophageal cancer : Experience from a large single-center cohort.
Nicolay NH; Rademacher J; Oelmann-Avendano J; Debus J; Huber PE; Lindel K
Strahlenther Onkol; 2016 Jul; 192(7):458-66. PubMed ID: 27245818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
